Recombinant Human Erythropoiesis Injection (CHO cell)
Sponsors
Shenyang Sunshine Pharmaceutical Co., LTD., Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd
Conditions
Chronic Renal Failure With HemodialysisPatient of Anemia in Chronic Renal Failure With Hemodialysis
Phase 2
Study of rESP Injection for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis
NCT03950687
Start: 2019-06-24End: 2020-12-30Target: 150Updated: 2020-03-09
A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis
NCT04231292
Start: 2020-03-01End: 2022-12-31Target: 105Updated: 2020-01-18